$BKKT

ALFRED MICHAEL purchased $2.2M of BKKT (indirect holdings)

ALFRED MICHAEL purchased 280,000 indirectly-held shares of Bakkt, Inc. (BKKT) at an average of $7.75 ($7.71–$7.83, $2.17M total) across 2 trades over 2026-06-09 to 2026-06-10.

Original reporting
SEC EDGAR · ALFRED MICHAEL
Published Jun 11, 2026, 8:50 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 11, 2026, 8:53 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$BKKT
Bullish
medium confidence
Mentioned
$BKKT
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$BKKTBullishLow
01

Why it matters

The newest concrete fact is the director’s open-market purchase size ($2.17M) and post-transaction holdings (905,000 shares).

02

Market read

Provides a fresh, primary-source datapoint on insider buying, which can modestly influence sentiment but is unlikely to drive a sustained repricing without additional fundamentals.

03

What to watch

Because the filing covers two days and provides a price range, traders should check whether the stock moved materially around those dates; absent other news, the signal may fade quickly.

Relevance 7/10Novelty 8/10Timing: SEC Form 4 filed June 11 (covering buys June 9–10)

Background

The filing is an SEC Form 4 insider transaction disclosure for Bakkt, Inc., reported from SEC EDGAR.

Company-level read

Ticker impact

$BKKTBullishMedium confidence
Context

Director Alfred Michael bought 280,000 shares of Bakkt in open-market trades totaling about $2.17M, disclosed via SEC Form 4.

Expected impact

Likely limited near-term impact; any effect is more sentiment/positioning than a re-rating catalyst.

Evidence & confidence

The article is a primary-source insider transaction with clear size and pricing, but insider buys typically have weak, short-lived price effects absent accompanying company news.

Market effects

No direct sector read-through; this is company-specific ownership activity.

None indicated.

None indicated.

Counterpoint

The buy is indirect and not tied to a 10b5-1 plan per the filing, but it can still reflect diversification, liquidity needs, or pre-existing intent rather than a new fundamental view.

Key entities

  • Bakkt, Inc.

    Subject of the SEC Form 4 insider transaction; director Alfred Michael purchased shares.

  • ALFRED MICHAEL

    Director who reported open-market purchases of BKKT shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$BKKTLow

Bakkit Expands, Shares Jump

Bakkt (NYSE: BKKT) shares rose 5.4% to $8.70 after announcing an expansion of its global commercial team. The company added senior executives with expertise in institutional markets, payments, and digital assets to accelerate product commercialization and strategic partnerships. New hires include Aman Ghose, Mark Hiriart, and Dean Salmon.

$BKKTMedAI 8/10

Bakkt (BKKT) Q2 2026 Earnings Call Transcript

Bakkt (BKKT) reported Q2 2026 revenue of $170.1 million, down 70% from $568.1 million, citing client transitions and weaker digital asset trading volumes. GAAP net income was $80.8 million, driven mainly by a $98.5 million non-cash gain from Transchem warrants. Total transacting volume was $168.8 million; management reiterated an EBITDA breakeven target in Q4 2026.

$BKKTMed

Bakkt Inc (BKKT) (Q2 2026) Earnings Call Highlights: Strong GAAP Net Income

Bakkt’s CEO Akshay Naheta said the company expects adjusted EBITDA break-even in Q4 2026, without a specific date, citing execution and client activations. Management discussed take rates, cross-border margins, and reaffirmed a 2026 TTV target of about $2.5 billion. The firm outlined post-DTR acquisition progress and Bakkt Agent MAU target of ~25,000 by year-end 2026.

$BKKTMed

Bakkt Reports Second Quarter 2026 Results - GAAP net income of $80.8 million, or $1.96 per basic and $1.94 per diluted share - Six commercial offerings live…

Bakkt, Inc. (BKKT) filed an SEC Form 8-K — Results of Operations and Financial Condition. Bakkt Reports Second Quarter 2026 Results - GAAP net income of $80.8 million, or $1.96 per basic and $1.94 per diluted share - Six commercial offerings live across Bakkt Markets; Total Transacting Volume (“TTV”) of $168.8 million in Q2, including payments volume generated on acqu